OceansBIo

Changwon, South Korea Founded: 2021 • Age: 5 yrs
Electroceutical devices for epilepsy treatment are developed with AI integration.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products 1 Services tracked
Competitors 9 Brand Intelligence

About OceansBIo

OceansBIo is a company based in Changwon (South Korea) founded in 2021. OceansBIo offers products and services including TaVNS. OceansBIo operates in a competitive market with competitors including NeuroPace, Cadence Neuroscience, Engage Therapeutics, NightWatch and Cyberonics, among others.

  • Headquarter Changwon, South Korea
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Oceansbio Co., Ltd.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of OceansBIo

OceansBIo is a publicly listed company on the KRX with ticker symbol 332190 in South Korea, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 332190 · Sector: Technology services · South Korea

Products & Services of OceansBIo

OceansBIo offers a comprehensive portfolio of products and services, including TaVNS.

Product name locked
Category locked
Primary

Device that delivers impulses to vagus nerve for neurological relief.

Funding Insights of OceansBIo

Investors in OceansBIo

OceansBIo has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include SNU Holdings, Korea Credit Guarantee Fund and D.CAMP.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
-
Locked Locked Locked
-
Locked Locked Locked
Premium access

Investor details for OceansBIo

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by OceansBIo

Investments
Premium access

Investment portfolio details for OceansBIo

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - OceansBIo

Premium access

Detailed financials for OceansBIo

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Oceansbio Comparisons

OceansBIo Primary company
Description
Electroceutical devices for epilepsy treatment are developed...
Location
Changwon, South Korea
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for OceansBIo

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of OceansBIo

OceansBIo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroPace, Cadence Neuroscience, Engage Therapeutics, NightWatch and Cyberonics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Implantable neurostimulation systems for epilepsy treatment are developed.
Locked Locked Locked
Medical devices for treating neurological disorders like epilepsy are developed.
Locked Locked Locked
Inhaled drug-device combo as rescue treatment for uncontrolled epileptic seizures
Locked Locked Locked
Wearable armbands for detecting epileptic seizures during sleep are offered.
Locked Locked Locked
Vagus nerve stimulation therapy is developed for epilepsy and depression.
Locked Locked Locked
Neuro-therapy solutions are developed for drug-resistant epilepsies and disorders.
Premium access

Detailed competitors of OceansBIo

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Oceansbio

Premium access

Complete news archive for OceansBIo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about OceansBIo

OceansBIo was founded in 2021 and raised its 1st funding round 2 years after it was founded.

OceansBIo is headquartered in Changwon, South Korea. It is registered at Changwon, Gyeongsangnam-do, South Korea.

Founded in 2021 and based in Changwon, South Korea, electroceutical devices for epilepsy treatment are developed by the company. Implantable human devices are created using AI technology within the medical device sector. Operations focus on advancing therapeutic solutions for neurological conditions, with emphasis on precise, AI-driven interventions tailored to epilepsy management.

OceansBIo's top competitors include NeuroPace, Engage Therapeutics and Cyberonics.

OceansBIo offers TaVNS.

Yes, OceansBIo is publicly traded on KRX under the ticker symbol 332190.

OceansBIo has 3 investors. Key investors include SNU Holdings, Korea Credit Guarantee Fund, and D.CAMP.

The ticker symbol of OceansBIo is 332190 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available